Released the easy-to-use ENO-20 to meet demand amidst growing interest in NOx research.
20 to meet demand amidst growing interest in NOx research.
Released the DR-V automatic blood collection device. It is capable of collecting blood from four subjects at the same time.
Began offering an "eserine-free" ACh high sensitivity application, which does not use the degradative enzyme inhibitor (eserine) most commonly used for ACh dialysis. It is capable of a sensitivity of 10fmol or less.
Released DR-VS, a simple device for collecting blood from a single subject.
Released HTEC-500, an HPLC with Eicom's unique integrated and compact design. It features dramatically improved operability and stability, along with improved sensitivity up to monoamine 0.03pg. This also increased the number of dialysis applications.
Released ACh application along with the 100 Series, the first-generation HPLC-ECD.
Until this point it was common to use two pumps; using a single pump for ACh measurement helps to reduce noise and increase sensitivity.
Developed a system that combines microdialysis and HPLC. Since then, only Eicom has continued to provide this as a total solution that covers everything from collection to measurement.
Continued to release monoamine applications beginning with ACh.
The spread of microdialysis has led to a leap in research in the field of neuroscience.
Released the 300 Series with the goal of reaching even higher sensitivity. It is capable of a detection sensitivity of 0.1pg or less for monoamines.
Began releasing biosensors targeting glutamate, glucose, lactate, etc.